BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231212T110000
DTEND;TZID=America/New_York:20231212T120000
DTSTAMP:20260415T114301
CREATED:20231212T154016Z
LAST-MODIFIED:20231212T170545Z
UID:4291-1702378800-1702382400@www.mdtechcouncil.com
SUMMARY:NIH Technology Opportunity Webinar: Nestorone
DESCRIPTION:Register to attend a free NIH webinar. Attendees will learn about a first-of-its-kind male contraceptive hormonal gel\, Nestorone®/Testosterone (NES/T)\, co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical\, daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of ending application. This presentation will showcase NES/T gel as an innovative\, user-controlled option for male contraception. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nih-technology-opportunity-webinar-nestorone-testosterone-male-contraceptive-gel/
LOCATION:Virtual Event
END:VEVENT
END:VCALENDAR